Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?

Avindra Nath1, Joseph Steiner2

  • 1Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Experimental Neurology
|November 20, 2013
PubMed
Abstract

No abstract available in PubMed .